Search Orphan Drug Designations and Approvals
-
| Generic Name: | Autologous olfactory neural progenitors |
|---|---|
| Date Designated: | 02/01/2008 |
| Orphan Designation: | Treatment of spinal cord injury patients with ASIA Impairment grades A, B, or C |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
RhinoCyte, Inc. 201 E. Jefferson Street Louisville, Kentucky 40202 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







